Join the 200th Anniversary Celebration

Images in Clinical Medicine

Kim Eagle, M.D., Editor

Gingival Hypertrophy in Myelomonocytic Leukemia

Stan H.M. van Uum, M.D., and Jo-Jan Keuning, M.D., Ph.D.

N Engl J Med 1994; 330:826March 24, 1994

Article

Figure 1 Gingival Hypertrophy in Myelomonocytic Leukemia.

A 36-year-old woman with chronic myelomonocytic leukemia had marked gingival hypertrophy, thought to be due to infiltration of the gingiva by leukemic cells. The patient presented with a white-cell count of 28,800 per cubic millimeter, with 23 percent monocytes and 2 percent monoblasts, a hematocrit of 20 percent, and a platelet count of 156,000 per cubic millimeter. Treatment with etoposide, idarubicin, and cytarabine resulted in a clinical remission, with resolution of the gingival lesions.

Kim Eagle, M.D.

Stan H.M. van Uum, M.D.
University Hospital, Nijmegen 6500 HB, the Netherlands

Jo-Jan Keuning, M.D., Ph.D.
Saint Joseph Hospital, Veldhoven 5500 MB, the Netherlands

Citing Articles (1)

Citing Articles

  1. 1

    FILIZ VURAL, MEHMET ALI OZCAN, G HAYRI OZSAN, FATIH DEMIRKAN, OZDEN PISKIN, HALIL ATES, AYDANUR KARGI, BULENT UNDAR. (2004) Gingival Involvement in a Patient with CD56 + Chronic Myelomonocytic Leukemia. Leukemia & Lymphoma 45:2, 415-418
    CrossRef